A detailed history of American International Group, Inc. transactions in Biovie Inc. stock. As of the latest transaction made, American International Group, Inc. holds 6,454 shares of BIVI stock, worth $2,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,454
Previous 6,007 7.44%
Holding current value
$2,581
Previous $7,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.53 - $1.89 $236 - $844
447 Added 7.44%
6,454 $3,000
Q4 2023

Feb 13, 2024

BUY
$1.22 - $5.24 $5,307 - $22,794
4,350 Added 262.52%
6,007 $7,000
Q3 2023

Nov 13, 2023

BUY
$2.75 - $5.17 $162 - $305
59 Added 3.69%
1,657 $5,000
Q2 2023

Aug 04, 2023

BUY
$4.09 - $8.29 $6,535 - $13,247
1,598 New
1,598 $6,000

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $12.1M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.